Healthcare | 06 May 2022 | Analysis
Is On-demand Healthcare Taking Off?
When the pandemic crisis struck, as a mode of business continuity, many Asia Pacific (APAC) countries accelera...Read more
Pharma | 06 May 2022 | Analysis
5 Transformative Merits of Blockchain in Pharma
Blockchain - an open, decentralised, secure, public ledger and the technology behind crypto currencies like bi...Read more
Singapore | 15 June 2022 | News
Takeda's dengue vaccine provides continued protection from dengue through 4.5 yrs of clinical trials
Japanese pharmaceutical firm Takeda has announced that its dengue vaccine candidate, TAK-003, p...Read more
Korea | 06 June 2022 | News
Korean startups ILIAS Biologics and HK inno.N join hands for new biomedicines
South Korean startup ILIAS Biologics has signed a Memorandum of Understanding (MoU) with HK inno.N for joint r...Read more
New Zealand | 06 June 2022 | News
New Zealand to design risk-prediction tool to help patients predict asthma attacks
A project to develop a real-time risk-prediction tool that takes information from the environment and smart de...Read more
Singapore | 26 May 2022 | News
Singapore links fatty liver with increased risk of cardiovascular disease
Patients with non-alcoholic fatty liver disease (NAFLD) are at higher risk of cardiovascular disease, because ...Read more
Thailand | 26 May 2022 | News
Thailand invents rapid detection test for gastrointestinal cancer
Researchers at Chula Engineering and Chula Medicine departments in Chulalongkorn University, Thailand have co-...Read more
Korea | 26 May 2022 | News
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has unveiled a global initi...Read more
China | 06 June 2022 | News
WuXi Biologics launches first commercial drug product facility for pre-filled syringes in China
WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO) service company...Read more
Japan | 12 May 2022 | News
Crown Bioscience to provide preclinical and translational services in Japan
US-based Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, have a...Read more
Targeting DRUG DELIVERY
In recent years, several innovations have emerged around long-acting formulations and medical device development to improve patient compliance. Consequently, the growing need for controlled drug release coupled with technological advancements in pharmacology is promoting the adoption of novel drug delivery systems (NDDS). It is now crucial for Asia Pacific (APAC) drug formulators to learn and act upon these advances in therapeutic modalities that address long-standing bioavailability, dosage, and ingestion challenges of drug components to remain competitive in the global market. Simultaneously, it’s essential to optimise the therapeutic efficacy and safety profiles of a drug by regulating dosage parameters, while DDS plays an important role in administering drugs, vaccines, and therapeutic agents. Optimising these techniques enhance the performance efficacy ratio of medications by economically managing therapeutics assets. Let’s examine recent advancements in drug delivery modalities that are greatly encouraging stakeholders’ collaboration among innovators, manufacturers, investors, and contract development and manufacturing companies (CDMOs) who are capitalising on competitive advantages.
For Feedback Email Us : communications@biospectrumasia.com
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
